HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

James J Lah Selected Research

Detergents (Detergent)

1/2021Targeted Quantification of Detergent-Insoluble RNA-Binding Proteins in Human Brain Reveals Stage and Disease Specific Co-aggregation in Alzheimer's Disease.
1/2018Characterization of Detergent Insoluble Proteome in Chronic Traumatic Encephalopathy.
12/2016Changes in the detergent-insoluble brain proteome linked to amyloid and tau in Alzheimer's Disease progression.
5/2012Quantitative analysis of the detergent-insoluble brain proteome in frontotemporal lobar degeneration using SILAC internal standards.
11/2011Aberrant septin 11 is associated with sporadic frontotemporal lobar degeneration.
11/2009Proteomics analysis reveals novel components in the detergent-insoluble subproteome in Alzheimer's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


James J Lah Research Topics

Disease

68Alzheimer Disease (Alzheimer's Disease)
01/2022 - 05/2003
20Cognitive Dysfunction
01/2022 - 02/2006
17Neurodegenerative Diseases (Neurodegenerative Disease)
01/2021 - 01/2006
10Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar)
11/2013 - 11/2009
7Disease Progression
07/2021 - 12/2010
7Amyloid Plaque
07/2021 - 08/2004
7Parkinson Disease (Parkinson's Disease)
01/2021 - 01/2012
6Inflammation (Inflammations)
01/2022 - 01/2017
6Neuroinflammatory Diseases
06/2021 - 01/2017
6Dementia (Dementias)
01/2020 - 02/2016
4Frontotemporal Dementia (Semantic Dementia)
01/2021 - 03/2010
2Tauopathies
01/2021 - 01/2018
2Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
08/2012 - 04/2010
2TDP-43 Proteinopathies
01/2012 - 04/2010
1Edema (Dropsy)
07/2021
1Intracranial Arteriosclerosis (Cerebral Atherosclerosis)
01/2020
1Hypercholesterolemia
01/2019
1Chronic Traumatic Encephalopathy
01/2018
1Down Syndrome (Down's Syndrome)
04/2014
1Corticobasal Degeneration
11/2013
1Neuroblastoma
04/2012
1Amyloidosis
03/2012

Drug/Important Bio-Agent (IBA)

44Proteins (Proteins, Gene)FDA Link
01/2022 - 05/2003
15Biomarkers (Surrogate Marker)IBA
01/2022 - 08/2004
13Amyloid (Amyloid Fibrils)IBA
07/2021 - 05/2003
13ProteomeIBA
05/2021 - 08/2004
8Amyloid beta-PeptidesIBA
01/2021 - 05/2003
7Apolipoproteins E (ApoE)IBA
01/2022 - 06/2006
7ApolipoproteinsIBA
01/2019 - 08/2004
7DNA-Binding Proteins (DNA Binding Protein)IBA
11/2013 - 03/2010
6Detergents (Detergent)IBA
01/2021 - 11/2009
6UbiquitinIBA
10/2018 - 10/2007
5RNA (Ribonucleic Acid)IBA
01/2022 - 05/2012
5RNA-Binding Proteins (RNA-Binding Protein)IBA
01/2021 - 01/2012
5Peptides (Polypeptides)IBA
01/2020 - 12/2010
4LipidsIBA
01/2021 - 01/2008
4Protein AggregatesIBA
10/2018 - 11/2009
4U1 Small Nuclear RibonucleoproteinIBA
01/2018 - 10/2013
3Pharmaceutical PreparationsIBA
01/2022 - 08/2010
3Biological ProductsIBA
07/2021 - 02/2015
3Phosphotransferases (Kinase)IBA
01/2021 - 12/2010
2Norepinephrine (Noradrenaline)FDA LinkGeneric
01/2022 - 01/2018
2IsotopesIBA
01/2019 - 05/2012
2Carrier Proteins (Binding Protein)IBA
01/2019 - 02/2015
2CholesterolIBA
01/2019 - 01/2008
2sarkosylIBA
12/2016 - 12/2014
2Threonine (L-Threonine)FDA Link
02/2015 - 11/2013
2Small Nuclear Ribonucleoproteins (snRNP)IBA
12/2014 - 04/2014
2Nuclear Proteins (Protein, Nuclear)IBA
07/2013 - 08/2012
2SynucleinsIBA
06/2013 - 04/2012
2DNA (Deoxyribonucleic Acid)IBA
11/2011 - 12/2010
2PolyubiquitinIBA
03/2011 - 04/2010
2LDL Receptors (LDL Receptor)IBA
02/2011 - 08/2004
2thioflavin TIBA
01/2006 - 08/2004
1Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric
01/2022
1CytokinesIBA
01/2022
1Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA
01/2022
1OsteoprotegerinIBA
01/2022
1solanezumabIBA
07/2021
1gantenerumabIBA
07/2021
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
06/2021
1Mitogen-Activated Protein KinasesIBA
06/2021
1Bile Acids and Salts (Bile Acids)IBA
01/2021
1Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
01/2021
1EndocannabinoidsIBA
01/2021
1OxylipinsIBA
01/2021
1Fatty Acids (Saturated Fatty Acids)IBA
01/2021
1Epoxide HydrolasesIBA
01/2021
1TabletsIBA
01/2021
1SteroidsIBA
01/2021
1moesinIBA
01/2020
1SugarsIBA
01/2020
1microtubule-associated protein 1B (MAP5)IBA
01/2020
1MicroRNAs (MicroRNA)IBA
01/2020
1ELAV-Like Protein 2IBA
01/2020
1Messenger RNA (mRNA)IBA
01/2020
1LDL CholesterolIBA
01/2019
1Arginine (L-Arginine)FDA Link
01/2019
1Apolipoproteins B (ApoB)IBA
01/2019
1DipeptidesIBA
01/2018
1NeurotoxinsIBA
01/2018
1DSP 4 (DSP-4)IBA
01/2018
1Potassium Channels (Potassium Channel)IBA
01/2017
1Complement Factor H (Factor H)IBA
02/2016
1Complement C3 (C3 Complement)IBA
02/2016
1Presenilin-1IBA
01/2016
1amyloid beta-protein (1-42)IBA
02/2015
1Alanine (L-Alanine)FDA Link
02/2015
1Small Heat-Shock ProteinsIBA
01/2015
1RNA Splicing FactorsIBA
11/2014
1Small Nuclear RNA (snRNA)IBA
07/2014
1Interleukin-23 (Interleukin 23)IBA
11/2013
1gephyrinIBA
11/2013
1Membrane Proteins (Integral Membrane Proteins)IBA
01/2013
1LuciferasesIBA
04/2012
1Small Interfering RNA (siRNA)IBA
04/2012
1Aryldialkylphosphatase (Paraoxonase)IBA
01/2012
1Oxygen (Dioxygen)IBA
01/2012

Therapy/Procedure

3Therapeutics
01/2022 - 11/2009
3Lasers (Laser)
01/2011 - 08/2004